Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Buprenorphine Initiation for Opioid Use Disorder
NCT05450718Phase 4Recruiting
- Sponsor
- Montefiore Medical Center
- Start
- Nov 2024
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of buprenorphine + naloxone in opioid use disorder (OUD), sponsored by Montefiore Medical Center. Started Nov 2024; status: recruiting.
02
Drugs
buprenorphine + naloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT05450718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05450718.